HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$0.38
Day range
$0.38 - $0.40
Year range
$0.28 - $4.30
Market cap
12.69M USD
Avg Volume
1.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 169.00K | 39.67% |
Operating expense | 7.96M | -39.74% |
Net income | -7.28M | 40.12% |
Net profit margin | -4.31K | 57.13% |
Earnings per share | — | — |
EBITDA | -7.79M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.70M | -53.41% |
Total assets | 36.13M | -52.58% |
Total liabilities | 4.04M | -68.06% |
Total equity | 32.09M | — |
Shares outstanding | 33.04M | — |
Price to book | 0.37 | — |
Return on assets | -48.19% | — |
Return on capital | -54.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.28M | 40.12% |
Cash from operations | -7.10M | 16.62% |
Cash from investing | 4.40M | 191.25% |
Cash from financing | -7.00K | -250.00% |
Net change in cash | -2.70M | 79.75% |
Free cash flow | -4.63M | -9.84% |
About
Founded
2003
Headquarters
Website
Employees
13
